Charles T Liamos's Net Worth

$31.6 Million

Estimate Recalculated Sep 12, 2024 03:10PM EST

Who is Charles T Liamos?

Charles T Liamos has an estimated net worth of $31.6 Million. This is based on reported shares across multiple companies, which include INSULET CORP, and THERASENSE INC.

SEC CIK

Charles T Liamos's CIK is 0001181286

Past Insider Trading and Trends

2014 was Charles T Liamos's most active year for acquiring shares with 12 total transactions. Charles T Liamos's most active month to acquire stocks was the month of February. 2014 was Charles T Liamos's most active year for disposing of shares, totalling 19 transactions. Charles T Liamos's most active month to dispose stocks was the month of March. 2014 saw Charles T Liamos paying a total of $1,606,605.34 for 140,037 shares, this is the most they've acquired in one year. In 2004 Charles T Liamos cashed out on 418,401 shares for a total of $6,857,512.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

INSULET CORP (PODD) Snapshot price: $214.75

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.62%
-6.21K
$24.21
-$165,132.95
87.58K
Scheduled
Mar 16 - Apr 1
Form 4
-6.90%
-6.95K
$23.83
-$285,287.23
93.78K
Scheduled
Mar 1 - Mar 2
Form 4
—
0
$23.91
-$64,720.00
100.73K
Scheduled
Feb 12
Form 4
—
0
$30.95
-$121,040.00
100.73K
Scheduled
Jan 2
Form 4
—
0
$30.75
-$119,400.00
100.73K
Scheduled
Dec 1
Form 4
—
0
$29.39
-$108,520.00
100.73K
Scheduled
Nov 3
Form 4
—
0
$26.20
-$83,040.00
100.73K
Scheduled
Oct 1
Form 4
—
0
$25.50
-$77,384.00
100.73K
Scheduled
Sep 10
Form 4
+4.14%
4K
—
—
100.73K
Jun 2
Form 4
-4.07%
-4.10K
$48.31
-$198,119.31
96.73K
Apr 1
Form 4
+30.42%
23.52K
$31.22
-$749,806.62
100.83K
Scheduled
Mar 1 - Mar 3
Form 4
—
0
$29.38
-$299,243.97
77.32K
Scheduled
Feb 3
Form 4
-34.70%
-41.08K
$26.33
-$2,710,769.80
77.32K
Scheduled
Dec 31 - Jan 3
Form 4
—
0
$23.90
-$1,576,834.02
118.19K
Scheduled
Dec 2 - Dec 3
Form 4
-20.24%
-30.00K
$25.71
-$2,057,287.28
118.19K
Scheduled
Nov 15 - Nov 18
Form 4
-1.94%
-2.93K
$26.00
-$76,232.00
147.95K
Apr 1
Form 4
+24.82%
30K
—
—
150.88K
Mar 1
Form 4
-8.97%
-11.92K
$21.22
-$252,878.74
120.88K
Dec 31
Form 4
+31.97%
32K
—
—
132.08K
Apr 1
Form 4
-10.64%
-11.92K
$18.83
-$224,397.11
100.08K
Dec 31
Form 4
+833.33%
100K
—
—
112K
Jan 10
Form 4
+50.00%
4K
—
—
12K
Jun 1
Form 4
—
0
—
—
0
Jul 30
Form 4
+166.67%
5K
$3.03
$15,128.00
8K
Mar 17
Form 4
∞
3K
$4.39
$13,181.00
3K
Nov 14 - Nov 17
Form 4
—
0
—
—
0
May 8
Form 3
—
0
—
—
0
No matching records found

THERASENSE INC No price found

COO and CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-85.88K
$27.00
-$2,318,760.00
0
Apr 5
Form 4
—
0
—
—
0
Jan 5
Form 4
-14.03%
-13.33K
$18.36
-$244,860.54
81.7K
Scheduled
Dec 26
Form 4
-6.56%
-6.67K
$17.90
-$119,339.30
95.03K
Scheduled
Dec 18
Form 4
-16.43%
-20.00K
$17.00
-$340,000.00
101.7K
Scheduled
Nov 17
Form 4
-0.00%
-1.00
$5.07
-$5.07
121.7K
Nov 3
Form 4
-14.11%
-20.00K
$18.00
-$360,048.00
121.7K
Scheduled
Oct 31
Form 4
-12.37%
-20.00K
$15.05
-$300,900.00
141.7K
Scheduled
Jul 28 - Jul 29
No matching records found